CASP1 and hepatocellular carcinoma: Regarding the hepatic activity of caspase-1, there were significant increases only in CHB patients compared with the normal control group, and there were no significant differences among the LC, HCC and normal control groups; furthermore, the hepatic activity was decreased in the ACLF group compared with the control CHB, LC and HCC groups (Fig. 2b).